FDA grants approval for Pfizer’s RSV vaccine
The US FDA has granted approval for Pfizer’s RSV vaccine, Abrysvo, for use in pregnant women to offer protection for their babies.
The US FDA has granted approval for Pfizer’s RSV vaccine, Abrysvo, for use in pregnant women to offer protection for their babies.
What's Your Reaction?
